The identification of PSEN1 p.Tyr159Ser mutation in a non-canonic early-onset Alzheimer's disease family

Arboleda-Velasquez, 2019, Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report, Nat. Med., 25, 1680, 10.1038/s41591-019-0611-3 Dubois, 2016, Preclinical Alzheimer’s disease: definition, natural history, and diagnostic criteria, Alzheimers Dement., 12, 292, 10.1016/j.jalz.2016.02.002 Eratne, 2018, Alzheimer's disease: clinical update on epidemiology, pathophysiology and diagnosis, Australas Psychiatry, 26, 347, 10.1177/1039856218762308 Frykman, 2017, Maturation and processing of the amyloid precursor protein is regulated by the potassium/sodium hyperpolarization-activated cyclic nucleotide-gated ion channel 2 (HCN2), Biochem. Biophys. Res. Commun., 483, 352, 10.1016/j.bbrc.2016.12.140 Jack, 2018, NIA-AA research framework: toward a biological definition of Alzheimer’s disease, Alzheimers Dement., 14, 535, 10.1016/j.jalz.2018.02.018 Kerchner, 2012, Novel presenilin-1 Y159F sequence variant associated with early-onset Alzheimer's disease, Neurosci. Lett., 531, 142, 10.1016/j.neulet.2012.10.037 Oikawa, 2019, Presenilins and γ-secretase in membrane proteostasis, Cells, 8, 10.3390/cells8030209 Sun, 2017, Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase, Proc. Natl. Acad. Sci. U. S. A., 114, E476, 10.1073/pnas.1618657114 Szaruga, 2017, Alzheimer's-causing mutations shift Aβ length by destabilizing γ-secretase-Aβn interactions, Cell, 170, 443, 10.1016/j.cell.2017.07.004